Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,950 Cr.
- Current Price ₹ 1,024
- High / Low ₹ 1,310 / 436
- Stock P/E 72.7
- Book Value ₹ 59.5
- Dividend Yield 0.00 %
- ROCE 39.8 %
- ROE 38.2 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.8%
Cons
- Stock is trading at 17.2 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -3.14%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 0 | 61 | 112 | |
| 0 | 43 | 72 | |
| Operating Profit | 0 | 18 | 39 |
| OPM % | 30% | 35% | |
| 0 | 0 | 2 | |
| Interest | 0 | 3 | 4 |
| Depreciation | 0 | 1 | 1 |
| Profit before tax | 0 | 15 | 37 |
| Tax % | 25% | 27% | |
| 0 | 11 | 27 | |
| EPS in Rs | 0.00 | 7.79 | 14.12 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 146% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 127% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 45% |
| Last Year: | 38% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.10 | 13 | 18 |
| Reserves | 0 | 14 | 95 |
| 0 | 27 | 33 | |
| 0 | 8 | 17 | |
| Total Liabilities | 0 | 63 | 163 |
| 0 | 12 | 39 | |
| CWIP | 0 | 6 | 42 |
| Investments | 0 | 4 | 4 |
| 0 | 41 | 79 | |
| Total Assets | 0 | 63 | 163 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -0 | 20 | 4 | |
| 0 | -26 | -61 | |
| 0 | 6 | 67 | |
| Net Cash Flow | 0 | 0 | 9 |
| Free Cash Flow | -0 | 0 | -59 |
| CFO/OP | 113% | 18% |
Ratios
Standalone / View Consolidated
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 100 | 124 | |
| Inventory Days | 102 | 100 | |
| Days Payable | 40 | 59 | |
| Cash Conversion Cycle | 162 | 165 | |
| Working Capital Days | 100 | 140 | |
| ROCE % | 64% | 40% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Annual Production Volume lakhs pieces |
|
|||
| Capacity Utilization Rate % |
||||
| Installed Production Capacity lakhs pieces |
||||
| Government Share of Revenue % |
||||
| Number of Distributors number |
||||
| Number of Retailers number |
||||
| Number of Super Stockists number |
||||
| Operational Manufacturing Lines number |
||||
Extracted by Screener AI
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
- Anondita Medicare says corporate governance compliance report is not applicable for quarter ended September 30, 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Submitted Regulation 74(5) confirmation certificate for quarter ended September 30, 2026.
-
Shareholders meeting
- Anondita Medicare filed AGM voting results and scrutinizer report for 29 September 2026.
-
Shareholders meeting
- Anondita Medicare held its 3rd AGM on September 29, 2026, approving financial statements and related-party items.
-
Copy of Newspaper Publication
- Newspaper advertisements published on September 29, 2026 for rights issue basis of allotment.
Concalls
-
Jun 2026PPT
-
May 2026Transcript PPT
-
Mar 2026PPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.